GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $5,000 | +25.0% | 150 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $4,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $4,000 | -71.4% | 150 | -62.5% | 0.00% | -75.0% |
Q2 2021 | $14,000 | -12.5% | 400 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $16,000 | -5.9% | 400 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $17,000 | -10.5% | 400 | +14.3% | 0.01% | -14.3% |
Q3 2020 | $19,000 | -13.6% | 350 | 0.0% | 0.01% | -12.5% |
Q2 2020 | $22,000 | +22.2% | 350 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $18,000 | -35.7% | 350 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $28,000 | – | 350 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |